Samsung Electronics said on Tuesday it had signed an agreement to acquire Xealth, a U.S.-based healthcare platform, as part of its efforts to expand its mobile healthcare services business. The South Korean company did...
Apollo Hospitals to spin off digi health, pharmacy business
Apollo Hospitals Enterprises (AHEL), the country’s largest listed healthcare chain, and its subsidiary Apollo HealthCo have decided to demerge their omnichannel pharma and digital health businesses (24×7...
Manipal Health Enterprises leads race to buy Sahyadri Hospitals with Rs 6,838 crore bid
IPO-bound Manipal Health Enterprises is leading the race to acquire Sahyadri Hospitals with a Rs 6,838 crore ($800 million) bid, people familiar with the matter said. It is trailed closely by Blackstone, they said...
PE firm True North exits Zydus Wellness; sells 7.27% stake for Rs 879 crore
Mumbai-based True North on Tuesday exited Zydus Wellness by divesting its entire 7.27 per cent stake in the company while PPFAS Mutual Fund acquired the shares for Rs 879 crore through an open market transaction...
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, aiming to strengthen its pipeline of experimental medicines, the Financial Times reported on Monday. The drug...
Manipal, Fortis in talks to raise Rs 5,000 cr for Sahyadri Hospitals bid
With the bidding deadline for Sahyadri Hospitals approaching on June 22, interested bidders including Manipal Health Enterprises and Fortis Healthcare are engaging with foreign lenders to raise financing of up to Rs...
Sahyadri Hospitals buyout: EQT, Blackstone-backed Quality Care, IHH & Manipal Hospitals may submit binding bids post
EQT, Blackstone- and TPG-backed platform Quality Care India, Temasek- and Dr Ranjan Pai-led Manipal Hospitals and Malaysia’s IHH are expected to submit final bids post the third week of June for the proposed...
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy
Bristol Myers Squibb (BMY.N) has agreed to pay up to $11.1 billion to partner with Germany’s BioNTech and develop the latter’s next-generation cancer immunotherapy, which could take on rival Merck &...
Sun Pharma’s Checkpoint buy: Why it’s a strategic fit in the new SPIL focus
India’s largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 million. This strategic move significantly strengthens Sun Pharma’s...
Mapmygenome goes global, acquires Canada’s Microbiome Insights
The acquisition includes Microbiome Insights’ CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome’s scientific prowess. Mapmygenome, a Hyderabad-headquartered AI-driven genomic and...
Metropolis Healthcare completes acquisition of Dr. Ahujas’ Pathology & Imaging Centre
Dapic Metropolis Healthcare (formerly known as Metropolis Histoxpert Digital Services), a wholly owned subsidiary of Metropolis Healthcare, has completed the acquisition of entire business of Dr. Ahujas’ Pathology...
Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline
Sanofi will acquire Vigil Neuroscience, a clinical-stage biotech company in a $470 million deal, the companies said on Thursday, as the French drugmaker seeks to boost its neurological pipeline through an...
